RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Cancers attributable to infectious agents in Nigeria
2012-2014
Odutola, M. K., Jedy-Agba, E. E., Oga, E., Igbinoba, F., Otu, T., Ezeome, E., Ekanem, I.-O., Hassan, R., & Adebamowo, C. A. (2016). Cancers attributable to infectious agents in Nigeria: 2012-2014. Journal of Clinical Oncology, 34(15_suppl). https://doi.org/10.1200/JCO.2016.34.15_suppl.e17035
Background: Infections by certain viruses, bacteria, and parasites have been identified as risk factors for some cancers. We carried out this study to evaluate the numbers of cancers in Nigeria from 2012-2014 that are attributable to infections using data from Population Based Cancer Registries [PBCR] in Nigeria. Methods: We considered cancers associated with Epstein-Barr virus [EBV], Human Papilloma Virus [HPV], Hepatitis B and C Virus [HBV/HCV], Human Immunodeficiency Virus and Human Herpes Virus 8 [HIV/HHV8], Helicobacter pylori and Schistosoma haematobium that have been classified as oncogenic by IARC. We obtained data on the infection associated cancers from the registry databases of 3 PBCR in Nigeria; Abuja, Enugu and Calabar cancer registries. We used PAF for infectious agents associated cancers in developing countries that were calculated using prevalence data and relative risk estimates in previous studies: EBV and Nasopharyngeal [90%], and Hodgkin’s Lymphoma [80%]; HPV and Cervical [100%], Vulval and Vaginal [40%], Anal [90%] and Oropharyngeal cancer [12%] in women, Penile [40%], Anal [90%] and Oropharyngeal cancer [12%] in men; HBV/HCV and Liver [92%], HIV/HHV8 and Kaposi sarcoma [100%], Non Hodgkin Lymphoma [100%]; H. pylori and stomach [74%] and S. haematobiumand Bladder cancer [56.6%]. Results: The 3 PBCR reported 4,861 cancer cases from 2012-2014; 1,875 in males and 2,986 in females. There were 412 infection-associated cancers in males accounting for 22% of total cancers in males, and 351 [85%] of these were attributed to infections. In female, there were 727 infection-associated cancers accounting for 24% of all cancers in females and of these, 674 [93%] were attributable to infections. Cancers of the Cervix [n = 430] and Liver [n = 152] as well as Non-Hodgkin’s Lymphoma [n = 129] were the commonest infection-associated cancers in both sexes. The commonest infectious agents associated with cancers were HPV [n = 453], HIV/HHV8 [n = 199], HBV/HCV [n = 143] and EBV [n = 125]. Conclusions: Our finding suggests that 85% of infection-associated cancers in males and 93% infection-associated cancers in females can be prevented with vaccination, safer risk behaviours, or antiinfective treatments.